(MEDI) Harbor Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US41151J8696 • Health
MEDI: Pharmaceuticals, Medical Devices, Biotechnology
The Harbor Health Care ETF (NYSE ARCA: MEDI) is a non-diversified exchange-traded fund primarily invested in equity securities, including common and preferred stocks, across various market capitalizations. Under normal market conditions, the fund allocates at least 80% of its net assets and investment-related borrowings to companies engaged in healthcare-related activities, such as research, development, production, or distribution of health care products and services. This focus allows the fund to target growth opportunities within the healthcare sector, including biotechnology, pharmaceuticals, and medical devices, which are critical for innovation and patient care.
From a technical perspective, MEDI is currently trading at $25.80, slightly below its short-term moving averages (SMA 20: $26.55, SMA 50: $26.08). The SMA 200 stands at $26.30, indicating a relatively stable long-term trend. The Average True Range (ATR) of 0.33 reflects low volatility, suggesting modest price fluctuations. However, with an average 20-day volume of just 1,952 shares, liquidity is limited, which may impact trading efficiency. The funds small size, with assets under management (AUM) of $15.98 million, further underscores its niche focus within the healthcare sector. Over the next three months, MEDIs price action is likely to remain range-bound between $25 and $27, influenced by sector-specific developments rather than broader market trends.
Additional Sources for MEDI ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MEDI ETF Overview
| Market Cap in USD | 16m |
| Category | Health |
| TER | 0.80% |
| IPO / Inception | 2022-11-16 |
MEDI ETF Ratings
| Growth 5y | 42.5% |
| Fundamental | - |
| Dividend | 22.8% |
| Rel. Strength Industry | -12.7 |
| Analysts | - |
| Fair Price Momentum | 24.17 USD |
| Fair Price DCF | - |
MEDI Dividends
| Dividend Yield 12m | 0.52% |
| Yield on Cost 5y | 0.70% |
| Annual Growth 5y | -45.89% |
| Payout Consistency | 75.9% |
MEDI Growth Ratios
| Growth Correlation 3m | 54.8% |
| Growth Correlation 12m | 16.1% |
| Growth Correlation 5y | 88.4% |
| CAGR 5y | 12.83% |
| CAGR/Max DD 5y | 1.04 |
| Sharpe Ratio 12m | -0.39 |
| Alpha | -12.28 |
| Beta | 0.65 |
| Volatility | 23.47% |
| Current Volume | 1.1k |
| Average Volume 20d | 1.3k |
As of March 14, 2025, the stock is trading at USD 25.45 with a total of 1,100 shares traded.
Over the past week, the price has changed by -2.70%, over one month by -4.50%, over three months by +0.46% and over the past year by -5.46%.
Partly, yes. Based on ValueRay Analyses, Harbor Health Care (NYSE ARCA:MEDI) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 42.45 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MEDI as of March 2025 is 24.17. This means that MEDI is currently overvalued and has a potential downside of -5.03%.
Harbor Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, MEDI Harbor Health Care will be worth about 26.6 in March 2026. The stock is currently trading at 25.45. This means that the stock has a potential upside of +4.52%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 26.6 | 4.5% |